Cell Signaling Technology Logo
1% for the planet logo
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

PRSS8 (F2Z4K) Rabbit mAb #15986

Filter:
  • WB

    Supporting Data

    REACTIVITY H M R
    SENSITIVITY Endogenous
    MW (kDa) 36
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 
    • M-Mouse 
    • R-Rat 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    PRSS8 (F2Z4K) Rabbit mAb recognizes endogenous levels of total PRSS8 protein.

    Species Reactivity:

    Human, Mouse, Rat

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Val98 of human PRSS8 protein.

    Background

    Prostasin (PRSS8), also known as channel activating protease 1 (CAP1), is a glycosylphosphatidylinositol (GPI)-anchored serine protease that is ubiquitously expressed in many tissues, including the small intestine, colon, esophagus, stomach, lung, skin, liver, prostate, kidney, and gallbladder (1). It acts as a proteolytic activator of the epithelial sodium channel in vitro and plays a major role in regulating sodium balance and glucose homeostasis (1,2). Aberrant PRSS8 expression has been associated with multiple cancers, including ovarian, prostate, breast, bladder, and gastric cancers (1). PRSS8 has been identified as a potential biomarker for early detection of ovarian cancer and, more recently, for Alzheimer’s disease (2,3). 
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.